|
International Neonatal Consortium (INC)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
INC accelerates the development of safe and effective therapies for neonates. The consortium engages the global neonatal community – families, neonatal nurses, academic scientists, regulators, pharmaceutical investigators, advocacy organizations, and funders – to focus on the needs of the neonate. Through teams that share data, knowledge, and expertise, INC will advance medical innovation and regulatory science for this underserved population.
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders'' Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, NCATS, NCI, NEI, NHGRI, NIAMS, NINDS
|
The International Rare Diseases Research Consortium (IRDiRC) teams up researchers and organizations investing in rare diseases research in order to achieve two main objectives by the year 2020, namely to deliver 200 new therapies for rare diseases and means to diagnose most rare diseases. A number of grand challenges are being addressed through collaborative actions to reach these 2020 goals such as establishing and providing access to harmonized data and samples, performing the molecular and clinical characterization of rare diseases, boosting translational, preclinical and clinical research, and streamlining ethical and regulatory procedures.
|
|
International TB Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
This is a working group of the Federal Tuberculosis (TB) Task Force. The International TB Working Group is chaired and organized by the US Agency for International Development (USAID). It meets monthly to coordinate international TB support.
|
|
Interoperability Standards Advisory Task Force of the Health Information Technology (HIT) Standards Committee
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NLM
|
The Interoperability Standards Advisory Task Force of the Health Information Technology (HIT) Standards Committee is part of the Federal Advisory Committee that is charged with making recommendations to the Office of the National Coordinator for Health Information Technology (ONC) on standards and implementation specifications to promote interoperability of computer systems and health information.
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NCI, NIAID, OD/ORS
|
Makes technically-based recommendations to the APHIS/CDC Select Agent and Toxin Program on restricted experiments with Select Agents and Toxins and the exclusion and exemption of attenuated strains. The Committee also conducts a biennial review of the Select Agents and Toxins list for HHS and overlap agents and toxins.
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID, OD/OSP
|
The ISATTAC is a working group of subject matter experts from the Federal Government formed by the Centers for Disease Control and Prevention (CDC) Director to provide recommendations to the CDC''s Division of Select Agents and Toxins in three technical areas: 1) review requests for exclusion of attenuated strains, 2) review requests to conduct restricted experiments, and 3) review select agents and toxins. The Committee conducts a biannual review, required by the Select Agent Rule, of the Select Agents and Toxins list for HHS.
|
|
Investigations of Early Life Determinants of Pediatric and Adult Malignancies in a Population
|
Research Initiative
|
CDC
|
NCI
|
In collaboration with investigators from the US Centers for Disease Control and Prevention (CDC) and the China CDC, the National Cancer Institute (NCI) is assessing the risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of peri-conception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated vs offspring of mothers not treated with folic acid supplements.
|
|
It’s a Noisy Planet. Protect Their Hearing® Public Education campaign
|
Public Education Campaign
|
CDC
|
NIDCD
|
The National Institute on Deafness and Other Communication Disorders (NIDCD) sponsors It’s a Noisy Planet Protect Their Hearing®, a national public education campaign to increase awareness among parents of children ages 8 to 12 about noise-induced hearing loss (NIHL) and how to prevent it. The campaign disseminates messages through print and digital materials, social media, community events, school presentations, and other methods. The CDC’s National Center for Environmental Health and National Institute for Occupational Safety and Health (NIOSH) have actively collaborated with the NIDCD for this campaign.
|
|
Joint Agency Microbiome Working Group (JAM)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NIAID, OD/DPCPSI/ODS
|
Promote trans-agency collaborations advancing microbiome-related research. Coordinate symposia and workshops to share research advances, identify scientific/technical knowledge gaps, support development of standards/resources, and update related regulatory activities/needs.
|
|
Joint Agency Nutrition (JAN) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK, NICHD, OD/DPCPSI/ODP, OD/DPCPSI/ODS
|
The Joint Agency Nutrition (JAN) was established to address gaps and opportunities in the areas of dietary supplements and nutrition research related to pregnant women and children and chronic diseases. The Working Group reports to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) Joint Leadership Council.
|